» Articles » PMID: 36006896

Infectious Disease Surveillance in U.S. Jails: Findings from a National Survey

Overview
Journal PLoS One
Date 2022 Aug 25
PMID 36006896
Authors
Affiliations
Soon will be listed here.
Abstract

While infectious diseases (ID) are a well-documented public health issue in carceral settings, research on ID screening and treatment in jails is lacking. A survey was sent to 1,126 jails in the United States to identify the prevalence of health screenings at intake and characteristics of care for ID; 371 surveys were completed correctly and analyzed. Despite conflicting Centers for Disease Control (CDC) guidance, only seven percent of surveyed jails test individuals for HIV at admission. In 46% of jails, non-healthcare personnel perform ID screenings. Jails in less urban areas were more likely to report healthcare screenings performed by correctional officers. Survey findings indicate that HIV, HCV and TB testing during jail admissions and access to PrEP are severely lacking in less urban jails in particular. Recommendations are provided to improve ID surveillance and address the burden of ID in correctional facilities.

Citing Articles

Incarceration history and HIV testing among people who inject drugs in the Boston metro area: a pooled cross-sectional study.

Bovell-Ammon B, Onofrey S, Kimmel S, Wurcel A, Klevens M Res Sq. 2025; .

PMID: 39764124 PMC: 11702856. DOI: 10.21203/rs.3.rs-5367945/v1.


Treating Hepatitis C Virus Infection in Jails as an Offset to Declines in Treatment Activity in the Community, New York City, NY, 2014-2020.

Chan J, Akiyama M, Julian E, Joseph R, McGahee W, Rosner Z AJPM Focus. 2024; 3(2):100185.

PMID: 38322001 PMC: 10844960. DOI: 10.1016/j.focus.2024.100185.


United States county jail treatment and care of pregnant incarcerated persons with opioid use disorder.

Benck K, Seide K, Jones A, Omori M, Brinkley Rubinstein L, Beckwith C Drug Alcohol Depend. 2023; 247:109863.

PMID: 37071946 PMC: 10198943. DOI: 10.1016/j.drugalcdep.2023.109863.

References
1.
Zaller N, Neher T, Presley M, Horton H, Marshall S, Zielinski M . Barriers to linking high-risk jail detainees to HIV pre-exposure prophylaxis. PLoS One. 2020; 15(4):e0231951. PMC: 7164641. DOI: 10.1371/journal.pone.0231951. View

2.
Beckwith C, Bazerman L, Cornwall A, Patry E, Poshkus M, Fu J . An evaluation of a routine opt-out rapid HIV testing program in a Rhode Island jail. AIDS Educ Prev. 2011; 23(3 Suppl):96-109. PMC: 3734962. DOI: 10.1521/aeap.2011.23.3_supp.96. View

3.
. Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC. Endorsed by the Advisory Council for the Elimination of Tuberculosis, the National Commission on Correctional Health Care, and the American.... MMWR Recomm Rep. 2006; 55(RR-9):1-44. View

4.
Joudrey P, Khan M, Wang E, Scheidell J, Edelman E, McInnes D . A conceptual model for understanding post-release opioid-related overdose risk. Addict Sci Clin Pract. 2019; 14(1):17. PMC: 6463640. DOI: 10.1186/s13722-019-0145-5. View

5.
Iroh P, Mayo H, Nijhawan A . The HIV Care Cascade Before, During, and After Incarceration: A Systematic Review and Data Synthesis. Am J Public Health. 2015; 105(7):e5-16. PMC: 4463395. DOI: 10.2105/AJPH.2015.302635. View